Analysis of hematological parameters as prognostic markers for toxicity and survival of (223)Radium treatment

(223)Radium ((223)Ra) has emerged as treatment prolonging survival in patients with metastatic castration-resistant prostate cancer (CRPC). As (223)Ra can cause hematotoxicity (HT), pre-existing hematopoiesis might influence the efficacy of (223)Ra and the rate of hematotoxicity, but as to our knowl...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Oncotarget
Hoofdauteurs: Leisser, Asha, Nejabat, Marzieh, Hartenbach, Markus, Agha Mohammadi Sareshgi, Reza, Shariat, Shahrokh, Kramer, Gero, Krainer, Michael, Hacker, Marcus, Haug, Alexander R.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Impact Journals LLC 2018
Onderwerpen:
Research Paper
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5882327/
https://ncbi.nlm.nih.gov/pubmed/29662636
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.24610
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items